Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Strategy to Avoid Excessive Oxygen Using an Autonomous Oxygen Titration Intervention

NCT: NCT06374225 · COMPLETED

NCT IDNCT06374225
StatusCOMPLETED
Start Date2024-04-29
Completion2026-01-09

Brief Summary

This study is a multicenter randomized controlled trial to determine the effectiveness of a closed loop/autonomous oxygen titration system (O2matic PRO100) to maintain normoxemia (goal range SpO2 90-96%, target 93%) during the first 72 hours of acute injury or illness, compared to standard provider-driven methods (manual titration with SpO2 target of 90-96%).

Frequently Asked Questions

What is Strategy to Avoid Excessive Oxygen Using an Autonomous Oxygen Titration Intervention?

Strategy to Avoid Excessive Oxygen Using an Autonomous Oxygen Titration Intervention is a clinical trial registered under NCT06374225. Current status: COMPLETED.

What is the status of NCT06374225?

The current status of NCT06374225 (Strategy to Avoid Excessive Oxygen Using an Autonomous Oxygen Titration Intervention) is: COMPLETED.

When did Strategy to Avoid Excessive Oxygen Using an Autonomous Oxygen Titration Intervention start?

Strategy to Avoid Excessive Oxygen Using an Autonomous Oxygen Titration Intervention started on 2024-04-29.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑